[Epithelial-mesenchymal transitions in cancer onset and progression]
- PMID: 20666011
[Epithelial-mesenchymal transitions in cancer onset and progression]
Abstract
Epithelial-mesenchymal transition (EMT) is a major process controlling multiple developmental events. The mesenchyme appeared as a transient state in diploblasts more than 800 million years ago. EMT has been conserved through evolution to control morphogenetic events, such as the formation of the three primary germ layers during gastrulation. Interestingly, related signal transduction pathways are remarkably conserved in many species. In the animal kingdom, EMT controls the intercellular adhesion machinery and its associated cytoskeleton. EMT pathways are also intimately involved in determination and differentiation programs, and are reactivated in adult tissues following injury or exposure to toxic agents. EMT is likely to play a role in early steps of carcinoma invasion, enabling blood or lymph vessel intravasation. Mesenchymal-like carcinoma cells undergo a mesenchymal to epithelial transition at distant sites from the primary tumor, and eventually form macrometastases. The mesenchymal-like state of cancer cells confers stemness, protection from cell death, immune escape and, most importantly, resistance to conventional and targeted therapies. Current strategies based on the EMT concept are aimed at designing new therapeutic approaches that interfere with the plasticity of carcinoma cells.
Similar articles
-
[Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma].Bull Cancer. 2010 Nov;97(11):1285-95. doi: 10.1684/bdc.2010.1206. Bull Cancer. 2010. PMID: 21084241 Review. French.
-
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Drug Resist Updat. 2008. PMID: 18718806 Review.
-
[Epithelial-mesenchymal transition in cancer progression].Postepy Biochem. 2009;55(2):121-8. Postepy Biochem. 2009. PMID: 19824467 Review. Polish.
-
Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers.Cells Tissues Organs. 2007;185(1-3):40-7. doi: 10.1159/000101301. Cells Tissues Organs. 2007. PMID: 17587806 Review.
-
[Role of epithelial-mesenchymal transition in tumor progression].Bull Acad Natl Med. 2009 Dec;193(9):2017-32; discussion 2032-4. Bull Acad Natl Med. 2009. PMID: 20666015 French.
Cited by
-
Mediator kinase module and human tumorigenesis.Crit Rev Biochem Mol Biol. 2015;50(5):393-426. doi: 10.3109/10409238.2015.1064854. Epub 2015 Jul 16. Crit Rev Biochem Mol Biol. 2015. PMID: 26182352 Free PMC article. Review.
-
AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.J Exp Med. 2017 Apr 3;214(4):1065-1079. doi: 10.1084/jem.20160903. Epub 2017 Mar 7. J Exp Med. 2017. PMID: 28270406 Free PMC article.
-
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.Cancer Cell. 2012 Jan 17;21(1):66-81. doi: 10.1016/j.ccr.2011.11.024. Cancer Cell. 2012. PMID: 22264789 Free PMC article.
-
Fibroblast growth factor 2 accelerates the epithelial-mesenchymal transition in keratinocytes during wound healing process.Sci Rep. 2020 Oct 29;10(1):18545. doi: 10.1038/s41598-020-75584-7. Sci Rep. 2020. PMID: 33122782 Free PMC article.
-
The Hallmarks of Flavonoids in Cancer.Molecules. 2021 Apr 2;26(7):2029. doi: 10.3390/molecules26072029. Molecules. 2021. PMID: 33918290 Free PMC article. Review.